Gerald D. van Eeckhout
Président chez EmboMedics, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Jafar Golzarian | M | - |
EmboMedics, Inc.
 EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 12 ans |
| Eric Madson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Robert Halverson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 9 ans |
| Reza Malek | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Lihui Weng | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Marc Sapoval | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Robert Cohen | M | 66 |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 2 ans |
| Paul Korus | M | 67 |
University of North Dakota
| 6 ans |
| Glenn Pomeroy | M | - |
University of North Dakota
| 7 ans |
| David S. Finn | M | - |
University of North Dakota
| 4 ans |
| Arlen Nordhagen | M | 67 |
University of North Dakota
| 4 ans |
| Jan P. Rudolf | M | - |
University of North Dakota
| 4 ans |
| Terry Stoa | M | - |
University of North Dakota
| 4 ans |
| Robert A. Miller | M | - |
University of North Dakota
| 4 ans |
| Joseph P. Peterson | M | - |
University of North Dakota
| 4 ans |
| Greg Gunderson | M | - |
University of North Dakota
| 5 ans |
| Pamela J. Moret | F | 68 |
University of North Dakota
| 4 ans |
| Scott D. Rued | M | 67 |
University of North Dakota
| 4 ans |
| Jody Feragen | F | 68 |
University of North Dakota
| 4 ans |
| Kevin Lemke | M | 71 |
University of North Dakota
| 4 ans |
| Kris E. Compton | F | - |
University of North Dakota
| 4 ans |
| Linda Pancratz | F | - |
University of North Dakota
| 3 ans |
| Jeffrey P. Vickers | M | 71 |
University of North Dakota
| 4 ans |
| Randy Newman | M | 70 |
University of North Dakota
| 4 ans |
| David Fennell | M | 70 |
University of North Dakota
| 4 ans |
| Craig B. Nelson | M | - |
University of North Dakota
| 4 ans |
| Nicholas L. Voller | M | 73 |
University of North Dakota
| 4 ans |
| Linda Laskowski | F | - |
University of North Dakota
| 5 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 28 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Gerald D. van Eeckhout
- Réseau Personnel
